R&D

>
Kelun R&D

 

Kelun has established the R&D team with more than 1800 researchers, introduced more than 100 leading scientists with international research experience in the field of generic drugs and innovative drugs in the global pharmaceutical industry, and quickly completed the construction of R&D system.

Kelun has successfully built an intensive research and development system with Chengdu Research Institute as the headquarter and Suzhou, Tianjin and New Jersey Research Institute as the branches.

Kelun has constructed 4 R&D systems, including generic drugs, NDDS, innovative small molecules and biomacromolecules.